Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (1) | Back to Search
Modified-release HPMC-AS based tablets fabricated by FDM 3D printing
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-C-012-Tuesday
- By: BUANZ, Asma (University College London, UCL School of Pharmacy, London, United Kingdom)
- Co-author(s): Alvaro Goyanes: FabRx Ltd, Kent, United Kingdom
Fabrizio Fina: UCL School of Pharmacy, University College London, London, United Kingdom
Annalisa Martorana: UCL School of Pharmacy, University College London, London, United Kingdom
Asma Buanz: UCL School of Pharmacy, University College London, London, United Kingdom
Simon Gaisford: UCL School of Pharmacy, University College London, London, United Kingdom;, FabRx Ltd, Kent, United Kingdom
Abdul Basit: UCL School of Pharmacy, University College London, London, United Kingdom;, FabRx Ltd, Kent, United Kingdom - Abstract:
Backgrounds
3D printing (3DP) offers the potential to revolutionise the future production of drug delivery systems. In fused-deposition modelling (FDM) printing, a polymer is heated and extruded through a small tip and solidified on a build plate to create an object. FDM technology can be used to print patient-tailored dose formulations with.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023